[This corrects the article DOI: 10.4103/2470-7511.312594.][This corrects the article DOI: 10.4103/2470-7511.312596.][This corrects the article DOI: 10.4103/2470-7511.320317.][This corrects the article DOI: 10.4103/2470-7511.320322.][This co...
Published Erratum
Cardiology plus. 2022 Jul-Sep;7(3):148-149. DOI:10.1097/CP9.0000000000000026 2022
Potential adverse effects of coronavirus disease 2019 on the cardiovascular system [0.03%]
新型冠状病毒肺炎对心血管系统潜在不良影响
Bing-Yin Wang,Bin-Quan You,Feng Liu
Bing-Yin Wang
Coronavirus disease 2019 (COVID-19) has spread, at an unprecedented speed and scale, into a global pandemic, infecting more than 29 million cases worldwide across 215 countries and territories and killing more than 930,000 individuals. Ther...
Left subclavian arterial thrombosis presenting as acute limb ischemia in a COVID-19 patient - An extreme rarity [0.03%]
左锁骨下动脉血栓导致的COVID-19患者的急性肢体缺血——一种极端罕见情况
Gajbiye Meenakshi,Bafna Akshay,Deore Kishore et al.
Gajbiye Meenakshi et al.
The peak of the coronavirus disease 2019 (COVID-19) crisis has exposed a substantial number of patients presenting with manifestations of venous and arterial thrombosis. Here, described is an extremely rare case of subclavian arterial throm...
Case Reports
Cardiology plus. 2020 Oct 1;5(4):203-206. DOI:10.4103/2470-7511.305418 2020
Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era [0.03%]
华法林与非维生素K口服抗凝药：新冠肺炎疫情下的口服抗凝药物选择策略
Heng Cai,Xin Zhou,Qing Yang
Heng Cai
Emerging evidence indicates that thromboembolic complications are a key determinant of inhospital mortality of patients with COVID-19. Prophylactic anticoagulation therapy is an important component of inhospital management of patients with ...
Expert consensus on nursing management for patients undergoing primary percutaneous coronary intervention during the COVID-19 pandemic [0.03%]
经皮冠状动脉介入治疗患者的护理管理专家共识（疫情期间版）
Yun-Lan Lu,Li Zhu,Gui-Hua Hou et al.
Yun-Lan Lu et al.
Jun Ren
Jun Ren
COVID-19-induced cardiovascular damage differs from other prevalent viruses [0.03%]
新冠肺炎引起的心血管损害与其他常见病毒不同
Rachel S Parise,Sindhu Ramesh,Manoj Govindarajulu et al.
Rachel S Parise et al.
Viral infections persist globally, among all ages, gender, and ethnicity. Of particular importance is COVID-19, associated with asymptomatic to severe symptoms, including complications/mortality. Cardiovascular disease (CVD) involves heart ...
Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic [0.03%]
COVID-19大流行期间ST段抬高型心肌梗死管理的挑战
Chor-Cheung Frankie Tam,Chung-Wah David Siu,Hung Fat Tse
Chor-Cheung Frankie Tam
The coronavirus disease-2019 (COVID-19) pandemic has brought unprecedented changes to our world and health-care system. Its high virulence and infectiousness directly infect people's respiratory system and indirectly disrupt our health-care...
Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2 [0.03%]
新冠肺炎患者的高血压处理：血管紧张素转换酶2的作用不容忽视
Guang-Hong Jia,James R Sowers
Guang-Hong Jia
The global coronavirus disease-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has created an unprecedented, global public health crisis. Epidemiological studies showed that hypertension is a ...
Expert consensus on operating procedures at chest pain centers in China during the coronavirus infectious disease-19 epidemic [0.03%]
新型冠状病毒疫情期间中国胸痛中心运行专家共识
Dingcheng Xiang,Yong Huo,Junbo Ge
Dingcheng Xiang
Chest Pain Committee of the Chinese Medical Doctor Association, Chinese College of Cardiovascular Physicians, China, Chest Pain Centers Alliance, Executive Committee of China Chest Pain Centers, China Cardiovascular Health Alliance, Headqua...